January 2, 2014

Cover Story

CEO of the Year

Utah’s business landscape is rich with professionals who have le...Read More

Featured Articles

Did you go Skiing this winter?

Around Utah

Sections

Spotlight
Martin Plaehn

Spotlight
Karen Sendelback

Legal Briefs
Social Media and Employers: Friends or Enemies?

Money Talk
The Case for HSAs

Economic Insight
Time to Show Up

Lessons Learned
Make a Move

TechKnowledge
In the Lab

EntrepreneurEdge
Rent to Own

Business Trends
Back from the Dead

Executive Living
Artful Inspiration

Features
A Breath of Fresh Air

Features
Worst-Case Scenario

Regional Report
Northern Utah

Focus
Measure Up

Industry Outlook
Travel & Tourism

Players
Players

Article

Fluorescent Probe Illuminates Cancer Research

Press Release

January 2, 2014


Salt Lake City – Researchers from Echelon Biosciences, Inc. and the University of Utah have reported that the use of ATX-Red AR-2, a new imaging agent, effectively illuminates tumors.

Published in November in the open-access journal PLOS ONE, the report describes the use of ATX-Red AR-2 for imaging breast cancer tumor masses in living mice.

"ATX-Red AR-2 is an exciting advancement for pre-clinical drug discovery and development, allowing researchers the ability to monitor diseases and drug candidates using a non-invasive, mechanism-specific diagnostic," said Dr. Chad Testa, vice president of research and development at Echelon Biosciences, Inc.

Visualizing the activity of the enzyme autotaxin (ATX) promotes the development of treatment for cancer and other diseases by allowing researchers to witness the effectiveness of a drug candidate in a live animal non-invasively, as no surgical procedure is required.

"Validating that your drug candidate works against its intended target in a living animal overcomes a significant hurdle in the therapeutic development process," Testa said.

Echelon Biosciences synthesized ATX-Red AR-2 to include proprietary dyes licensed from LI-COR Biosciences that emit light when viewed in the near-infrared spectrum, which is ideal for imaging in animals. When administered intravenously, ATX-Red AR-2 specifically targets ATX, which activates the probe causing it to emit light. In the absence of ATX there is no emission of light.

"Researchers can measure the effectiveness of their potential drug candidate by viewing the amount of light the probe emits—a decrease in signal reflects successful disease suppression," said W. Tim Miller, president and CEO of Echelon Biosciences.

ATX is essential in cell growth—in both normal physiology and in several diseases—with elevated levels found in many cancers, including those of the breast, pancreas, kidney and brain, and in arthritis, multiple sclerosis, Alzheimer's disease, neuropathic pain and obesity. There is considerable effort to develop drugs that are active against ATX, as this enzyme has a fundamental role in multiple diseases.

"If future studies show that ATX-Red AR-2 is as effective and safe as we think it is, this tool could be used to improve human health in several ways," said Dr. Damian Madan, lead author on the PLOS ONE publication. "Physicians could locate tumors more easily and determine if therapies are effective.”

Continued research of ATX-Red AR-2 demonstrates applications in tumor and arthritis treatment, as worldwide collaboration expands the potential of this technology.

Utah Business Social
UB Events View All
Content Marketing BootcampUtah Business Event
Oct 28, 2014
Please join Utah Business Magazine and Adobe, along with our other sponsors: Boostability, Right ...
Sustainable Business Awards 2014Utah Business Event
Nov 13, 2014
Utah Business magazine along with presenting sponsor Big D Construction, is pleased to announce t...
Best Companies to Work For 2014Utah Business Event
Dec 11, 2014
Utah Business magazine along with our sponsors Diversified Insurance and Miller Motor Sports Park...
Community Events View All
Deal Forum - Salt Lake City
Oct 22, 2014
This Deal Forum is a live pitch event and will feature a number of entrepreneurs who are seeking ...
Interwest Paper - Recycling Brokerage Tour
Oct 22, 2014
Learn about the recycling services ecosystem and what it takes to support customers in nine state...

info@utahbusiness.com  |  90 South 400 West, Ste 650 Salt Lake City, Utah 84101   |  (801) 568-0114

Advertise with Utah Business

Submit an Event

* indicates required information
* Event Name:
Price (general):
Website (if applicable):
Coordinator's Name:
Coordinator's Email:
Coordinator's Phone:
Venue Name:
Venue Address:
Venue City:
Venue Zip:
Event Capacity:
Date(s):
to
* Event Description:
  Cancel